Corrigendum to: EGFR, the Lazarus target for precision oncology in glioblastoma.
Corrigendum to: EGFR, the Lazarus target for precision oncology in glioblastoma.
复制标题
勘误表：EGFR，胶质母细胞瘤精准肿瘤学的 Lazarus 靶标。
DOI：
10.1093/neuonc/noac254
复制
发表时间：
2023
期刊：
影响因子：
15.9
通讯作者：
Miller,CRyan
中科院分区：
文献类型：
--
作者：
Lin,Benjamin;Ziebro,Julia;Smithberger,Erin;Skinner,KaseyR;Zhao,Eva;Cloughesy,TimothyF;Binder,ZevA;O'Rourke,DonaldM;Nathanson,DavidA;Furnari,FrankB;Miller,CRyan
在该手稿最初发表的版本中，在以下句子之后错误地省略了脚注48的引用：“缺失变体EGFRvII和EGFRvIII以及各种EGFR错义变体EGFRG 63 R、EGFRR 108 K、EGFRA 289 V和EGFRG 598 V在结构上会聚，通过去除N-TR 1片段中的空间位阻，组成性地暴露该隐藏表位。”
In the originally published version of this manuscript, a reference to footnote 48 was erroneously omitted after the sentence:“Deletion variants, EGFRvII and EGFRvIII, and assorted EGFR missense variants, EGFRG63R, EGFRR108K, EGFRA289V, and EGFRG598V structurally converge to constitutively expose this cryptic epitope by removing steric hinderance in the N-TR1 fragment.”